Tag Archives: Post-acute Sequelae of COVID-19

Research: ME/CFS is common in Long COVID patients

ME/CFS is common in PASC / long COVID   A US long COVID clinic found that 43% of PASC/ long COVID patients met the criteria for ME/CFS though they acknowledge that a larger more diverse group of patients might alter … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , , , , , , , , | Comments Off on Research: ME/CFS is common in Long COVID patients

Hypothesis: Multisystemic dyshomeostasis (faulty thermostat theory) in ME/CFS & PASC

Converging evidence of similar symptomatology of ME/CFS and PASC   A review article by independent researcher David Marks looks at the overlap in symptoms between ME/CFS and Long COVID and makes a speculative hypothesis about biological mechanisms. Conclusions: (1) The … Continue reading

Posted in News | Tagged , , , , , , , | Comments Off on Hypothesis: Multisystemic dyshomeostasis (faulty thermostat theory) in ME/CFS & PASC

Hypothesis: Circadian rhythm disruption in ME/CFS: implications for the post-acute sequelae of COVID-19

Circadian rhythm disruption in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for the post-acute sequelae of COVID-19, by Michael J McCarthy in Brain, Behavior, & Immunity – Health, Vol 20, March 2022, [doi.org/10.1016/j.bbih.2022.100412]   Highlights Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is characterized … Continue reading

Posted in News | Tagged , , , , , , , | Comments Off on Hypothesis: Circadian rhythm disruption in ME/CFS: implications for the post-acute sequelae of COVID-19

Research review: Immunoglobulin therapy for ME/CFS

Back to the Future? Immunoglobulin therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, by  Helen Brownlie and Nigel Speight in Healthcare 2021, 9(11), 1546; [doi.org/10.3390/healthcare9111546]   12 Nov 2021 (This article belongs to the Special Issue ME/CFS – the Severely and Very Severely Affected)   … Continue reading

Posted in News | Tagged , , , , , , , , | Comments Off on Research review: Immunoglobulin therapy for ME/CFS